Adventrx's job cuts continue
This article was originally published in Scrip
Executive Summary
Adventrx Pharmaceuticals will cut nearly two thirds of its staff in the company's third restructuring since its CEO resigned last October. The US firm will now have just five full-time employees, down from approximately 23 people six months ago.